1. Home
  2. IOSP vs VCEL Comparison

IOSP vs VCEL Comparison

Compare IOSP & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOSP
  • VCEL
  • Stock Information
  • Founded
  • IOSP 1938
  • VCEL 1989
  • Country
  • IOSP United States
  • VCEL United States
  • Employees
  • IOSP N/A
  • VCEL N/A
  • Industry
  • IOSP Major Chemicals
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • IOSP Industrials
  • VCEL Health Care
  • Exchange
  • IOSP Nasdaq
  • VCEL Nasdaq
  • Market Cap
  • IOSP 1.9B
  • VCEL 1.6B
  • IPO Year
  • IOSP 1998
  • VCEL 1997
  • Fundamental
  • Price
  • IOSP $72.86
  • VCEL $34.56
  • Analyst Decision
  • IOSP Strong Buy
  • VCEL Strong Buy
  • Analyst Count
  • IOSP 1
  • VCEL 6
  • Target Price
  • IOSP $155.00
  • VCEL $58.60
  • AVG Volume (30 Days)
  • IOSP 156.6K
  • VCEL 571.1K
  • Earning Date
  • IOSP 11-04-2025
  • VCEL 11-06-2025
  • Dividend Yield
  • IOSP 2.30%
  • VCEL N/A
  • EPS Growth
  • IOSP N/A
  • VCEL 2045.40
  • EPS
  • IOSP 0.77
  • VCEL 0.13
  • Revenue
  • IOSP $1,790,700,000.00
  • VCEL $249,119,000.00
  • Revenue This Year
  • IOSP N/A
  • VCEL $18.35
  • Revenue Next Year
  • IOSP $7.14
  • VCEL $22.26
  • P/E Ratio
  • IOSP $94.79
  • VCEL $258.55
  • Revenue Growth
  • IOSP N/A
  • VCEL 16.13
  • 52 Week Low
  • IOSP $72.33
  • VCEL $29.24
  • 52 Week High
  • IOSP $128.35
  • VCEL $63.00
  • Technical
  • Relative Strength Index (RSI)
  • IOSP 27.88
  • VCEL 47.93
  • Support Level
  • IOSP $73.39
  • VCEL $35.47
  • Resistance Level
  • IOSP $76.51
  • VCEL $36.99
  • Average True Range (ATR)
  • IOSP 1.44
  • VCEL 1.44
  • MACD
  • IOSP -0.04
  • VCEL -0.06
  • Stochastic Oscillator
  • IOSP 0.00
  • VCEL 33.62

About IOSP Innospec Inc.

Innospec Inc manufactures and sells a variety of chemicals and fuel additives. The firm organizes itself into three segments based on product type. The Fuel Specialties segment, which generates the majority of revenue, sells products used to improve fuel efficiency, boost engine performance, and reduce emissions for automobiles, boats, and airplanes. It also sells products used by oil field service providers in the extraction of oil and gas. The Performance Chemicals segment sells products to the personal-care industry. The Oilfield Services segment develops and markets products to prevent loss of mud.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: